At 55x trailing earnings, this stock screens optically expensive, but the 13x Forward P/E dramatically reframes the narrative — the market is pricing in a sharp earnings normalization. A PEG Forward of 1.4 suggests growth is not being given away cheaply, yet it is far from bubble territory. The real tension lies in the balance sheet: an Altman Z-Score of 1.9 signals elevated financial risk, not comfort. This is not a pristine compounder — it is a cyclical operator priced for recovery, where execution must validate the steep compression from 55x to 13x earnings or the equity multiple will not hold.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.